{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:40:10Z","timestamp":1746333610772,"version":"3.40.4"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T00:00:00Z","timestamp":1640822400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Candida bloodstream infection continues to be a significant cause of mortality in premature infants. Amphotericin B has been recommended as the primary treatment; however, its use is limited due to drug-induced nephrotoxicity and amphotericin B-resistant candidemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>The gestational age was 29 (+6) weeks, and birth weight was 1760\u200ag.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The infant was diagnosed with Candida parapsilosis bloodstream infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Fluconazole, 12\u200amg\/kg\/day, combined with caspofungin (loading dose 3\u200amg\/kg, at a maintenance dose of 2\u200amg\/kg every 24\u200ah) therapy was administered to premature infant with Candida bloodstream infection. When fluconazole or caspofungin was used to treat Candida bloodstream infection in preterm infants, the blood cultures of the infant remained positive for Candida parapsilosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>All persistent candidemia resolved on fluconazole combined with caspofungin therapy. There were no adverse effects, hepatotoxicity, nephrotoxicity, anemia, or thrombocytopenia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Fluconazole combined with caspofungin successfully treated Candida bloodstream infection in premature infants at 29\u200a+\u200a6 weeks\u2019 gestational age, but large-scale clinical trials are required.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028270","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T15:36:03Z","timestamp":1640878563000},"page":"e28270","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Successful fluconazole combined with caspofungin treatment of candida bloodstream infection in preterm infant"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1540-8370","authenticated-orcid":false,"given":"Gaole","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1746-2397","authenticated-orcid":false,"given":"Yingqiu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,30]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fped.2019.00375","article-title":"Antifungal drugs for invasive candida infections (ICI) in neonates: future perspectives","volume":"7","author":"Iliana","year":"2019","journal-title":"Front Pediatr"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"F127","DOI":"10.1136\/fnn.2006.097758","article-title":"Candida parapsilosis infection in very low birth weight infants","volume":"92","author":"Clerihew","year":"2007","journal-title":"Arch Dis Childhood Fetal Neonatal Ed"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"F454","DOI":"10.1136\/archdischild-2012-303350","article-title":"Update on the management of Candida infections in preterm neonates","volume":"100","author":"Manzoni","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R4-20250504","first-page":"115","article-title":"Review of fluconazole treatment and prophylaxis for invasive candidiasis in neonates","volume":"26","author":"Hornik","year":"2021","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Peter","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40262-017-0578-5","article-title":"Clinical pharmacokinetics and pharmacodynamics of micafungin","volume":"57","author":"Wasmann","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1097\/INF.0000000000000434","article-title":"Micafungin in premature and non-premature infants. A systematic review of 9 clinical trials","volume":"33","author":"Manzoni","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jac\/dkz398","article-title":"A randomized, double-blind trial investigating the efficacy of caspofungin versus amphotericin B deoxycholate in the treatment of invasive candidiasis in neonates and infants younger than 3 months of age","volume":"75","author":"Kim","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"R13-20250504","first-page":"605","article-title":"Pharmacokinetic, efficacy, and safety considerations for the use of antifungal drugs in the neonatal population","volume":"7","author":"Briana","year":"2020","journal-title":"Expert Opinion Drug Metab Toxicol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:03:04Z","timestamp":1746331384000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028270"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,12,30]]},"references-count":9,"journal-issue":{"issue":"52","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028270","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,12,30]]},"assertion":[{"value":"2021-11-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}